GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akums Drugs and Pharmaceuticals Ltd (NSE:AKUMS) » Definitions » Book Value per Share

Akums Drugs and Pharmaceuticals (NSE:AKUMS) Book Value per Share : ₹0.00 (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Akums Drugs and Pharmaceuticals Book Value per Share?

Akums Drugs and Pharmaceuticals's book value per share for the quarter that ended in Dec. 2024 was ₹0.00.

During the past 12 months, Akums Drugs and Pharmaceuticals's average Book Value Per Share Growth Rate was 306.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -6.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of Akums Drugs and Pharmaceuticals was -6.20% per year. The lowest was -6.20% per year. And the median was -6.20% per year.

Akums Drugs and Pharmaceuticals's current price is ₹529.95. Its book value per share for the quarter that ended in Dec. 2024 was ₹0.00. Hence, today's PB Ratio of Akums Drugs and Pharmaceuticals is .

During the past 4 years, the highest P/B Ratio of Akums Drugs and Pharmaceuticals was 23.00. The lowest was 2.63. And the median was 4.63.

Good Sign:

Akums Drugs and Pharmaceuticals Ltd stock PB Ratio (=2.63) is close to 1-year low of 2.63.


Akums Drugs and Pharmaceuticals Book Value per Share Historical Data

The historical data trend for Akums Drugs and Pharmaceuticals's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akums Drugs and Pharmaceuticals Book Value per Share Chart

Akums Drugs and Pharmaceuticals Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Book Value per Share
56.22 39.52 45.57 46.34

Akums Drugs and Pharmaceuticals Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24
Book Value per Share Get a 7-Day Free Trial 35.60 - 46.34 185.07 -

Competitive Comparison of Akums Drugs and Pharmaceuticals's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Akums Drugs and Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akums Drugs and Pharmaceuticals's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Akums Drugs and Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Akums Drugs and Pharmaceuticals's PB Ratio falls into.


;
;

Akums Drugs and Pharmaceuticals Book Value per Share Calculation

Akums Drugs and Pharmaceuticals's Book Value Per Share for the fiscal year that ended in Mar. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(7,095-0)/153
=46.34

Akums Drugs and Pharmaceuticals's Book Value Per Share for the quarter that ended in Dec. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(N/A-0)/153
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Akums Drugs and Pharmaceuticals  (NSE:AKUMS) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Akums Drugs and Pharmaceuticals Book Value per Share Related Terms

Thank you for viewing the detailed overview of Akums Drugs and Pharmaceuticals's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Akums Drugs and Pharmaceuticals Business Description

Traded in Other Exchanges
Address
Akums House, Plot No. 131 to 133, Block C, Mangolpuri Industrial Area Phase1, Adjoining CBSE Office, Delhi, IND, 110083
Akums Drugs and Pharmaceuticals Ltd a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. Its services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and Outside markets, and other testing services. It is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). The operates in three segments: a) Contract Development and Manufacturing Operations (CDMO), b) Active Pharmaceutical Ingredient (API), and c) Branded and Generic formulations. Key revenue is generated from Contract Development and Manufacturing Operations (CDMO).

Akums Drugs and Pharmaceuticals Headlines

No Headlines